RadioLigand Therapy with [177Lu]Lu-PSMA-617 for Salivary Gland Cancers: Literature Review and First Compassionate Use in France.
Pharmaceuticals (Basel)
; 16(5)2023 May 16.
Article
in En
| MEDLINE
| ID: mdl-37242537
Full text:
1
Collection:
01-internacional
Database:
MEDLINE
Type of study:
Prognostic_studies
Language:
En
Journal:
Pharmaceuticals (Basel)
Year:
2023
Document type:
Article
Affiliation country:
Country of publication: